Novo Nordisk A/S (NVO)

Novo Nordisk Stock Forecast

Stock Price Forecast

The 3 analysts that cover Novo Nordisk stock have a consensus rating of "Buy" and an average price target of $112, which forecasts a 51.33% increase in the stock price over the next year. The lowest target is $64 and the highest is $160.

Price Target: $112 (+51.33%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$64	$112	$160	$160
Change	-13.53%	+51.33%	+116.19%	+116.19%

* Price targets were last updated on Apr 17, 2025.

Analyst Ratings

The average analyst rating for Novo Nordisk stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	3	3	3	2	2	1
Buy	3	3	3	1	1	1
Hold	0	0	0	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	4	4	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Evan David Seigerman BMO Capital	BMO Capital	Buy → Hold Downgrades $105 → $64	Buy → Hold	Downgrades	$105 → $64	-13.53%	Apr 17, 2025
Jo Walton UBS	UBS	Strong Sell → Strong Buy Upgrades n/a	Strong Sell → Strong Buy	Upgrades	n/a	n/a	Jan 8, 2025
Evan David Seigerman BMO Capital	BMO Capital	Buy Maintains $156 → $105	Buy	Maintains	$156 → $105	+41.87%	Dec 23, 2024
Louise Chen Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates $160	Buy	Reiterates	$160	+116.19%	Nov 6, 2024
Evan David Seigerman BMO Capital	BMO Capital	Buy Maintains $160 → $156	Buy	Maintains	$160 → $156	+110.78%	Oct 17, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

344.40B

Increased by 18.59%

from 290.40B

Revenue Next Year

398.17B

Increased by 15.61%

from 344.40B

EPS This Year

27.09

Increased by 19.72%

from 22.63

EPS Next Year

33.20

Increased by 22.55%

from 27.09

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	126.95B	140.80B	176.95B	232.26B	290.40B	344.40B	398.17B	442.41B
Revenue Growth	4.04%	10.91%	25.68%	31.26%	25.03%	18.59%	15.61%	11.11%
EPS	9.01	10.37	12.22	18.62	22.63	27.09	33.20	37.37
EPS Growth	9.95%	15.16%	17.84%	52.37%	21.54%	19.72%	22.55%	12.55%
Forward PE	-	-	-	-	-	17.68	14.43	12.82
No. Analysts	-	-	-	-	-	26	26	21

Financial currency is DKK. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	379.1B	444.6B	513.9B
Avg	344.4B	398.2B	442.4B
Low	312.0B	346.6B	375.9B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	30.5%	29.1%	29.1%
Avg	18.6%	15.6%	11.1%
Low	7.4%	0.6%	-5.6%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	32.01	40.78	46.86
Avg	27.09	33.20	37.37
Low	24.55	28.09	30.69

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	41.5%	50.5%	41.1%
Avg	19.7%	22.6%	12.5%
Low	8.5%	3.7%	-7.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.